Concepedia

Author

Michiyo Yamano

Matsushita Memorial HospitalORCID

Also Known As

M Yamano, M. Yamano, MICHIYO YAMANO, Mayumi Yamano, Michiyo YAMANO, Michiyo Yamano

135

Publications

984

Citations

15

H-Index

47

Concepts

All Affiliations

Matsushita Memorial HospitalKyoto Prefectural University of MedicineDrug Discovery Laboratory (Norway)Central Research Laboratories (United Kingdom)
MY

About

Michiyo Yamano is an author at Matsushita Memorial Hospital specializing in medicine, cardiology, and cardiovascular imaging.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

273

2

Public Health

6

6

150

3

Health Sciences

2

2

44

4

Social Sciences

2

2

49

5

Nursing

1

1

13

Michiyo Yamano

×

26

Publications

765

Citations

15

H-Index

YearCitations

Role of the serotonin3 receptor in stress-induced defecation.

K Miyata, Takeshi Kamato, Akito Nishida,

Journal of Pharmacology and Experimental Therapeutics

1992

112

Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.

Akito Nishida, K Miyata, Rie Tsutsumi,

Journal of Pharmacology and Experimental Therapeutics

1994

88

Usefulness of High-Sensitivity Cardiac Troponin T and Brain Natriuretic Peptide as Biomarkers of Myocardial Fibrosis in Patients With Hypertrophic Cardiomyopathy

Tatsuya Kawasaki, Chieko Sakai, Kuniyasu Harimoto,

The American Journal of Cardiology

2013

84

Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.

K Miyata, Takeshi Kamato, Akito Nishida,

Journal of Pharmacology and Experimental Therapeutics

1991

55

YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.

Akito Nishida, Yusuke Takinami, Hidenobu Yuki,

Journal of Pharmacology and Experimental Therapeutics

1994

52

Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.

K Miyata, Takeshi Kamato, Michiyo Yamano,

Journal of Pharmacology and Experimental Therapeutics

1991

41

Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex

Hiroyuki Ito, Shinobu Akuzawa, Rie Tsutsumi,

Neuropharmacology

1995

39

Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats

Michiyo Yamano, Takeshi Kamato, Yukinori Nagakura,

Naunyn-Schmiedeberg s Archives of Pharmacology

1997

31

Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression

Akito Nishida, A. Kobayashi-Uchida, Shinobu Akuzawa,

American Journal of Physiology-Gastrointestinal and Liver Physiology

1995

29

Impact of Left Ventricular Diastolic Property on Left Atrial Function from Simultaneous Left Atrial and Ventricular Three-Dimensional Echocardiographic Volume Measurement

Michiyo Yamano, Tetsuhiro Yamano, Yumi Iwamura,

The American Journal of Cardiology

2017

26

Page 1